A1 Journal article (refereed)
The Platform Development, Adherence and Efficacy to a Digital Brief Therapy for Insomnia (dBTI) During the COVID-19 Pandemic (2022)
Xingchang, L., Yuanhui, L., Rui, Y., Hämäläinen, T., Dai, L., Shuai, L., Chenxi, Z., Yan, X., Xian, L., & Bin, Z. (2022). The Platform Development, Adherence and Efficacy to a Digital Brief Therapy for Insomnia (dBTI) During the COVID-19 Pandemic. Methods, 205, 39-45. https://doi.org/10.1016/j.ymeth.2022.04.016
JYU authors or editors
Publication details
All authors or editors: Xingchang, Liu; Yuanhui, Li; Rui, Yan; Hämäläinen, Timo; Dai, Li; Shuai, Liu; Chenxi, Zhang; Yan, Xu; Xian, Luo; Bin, Zhang
Journal or series: Methods
ISSN: 1046-2023
eISSN: 1095-9130
Publication year: 2022
Publication date: 05/05/2022
Volume: 205
Pages range: 39-45
Publisher: Elsevier
Publication country: United States
Publication language: English
DOI: https://doi.org/10.1016/j.ymeth.2022.04.016
Persistent website address: https://doi.org/10.1016/j.ymeth.2022.04.016
Publication open access: Other way freely accessible online
Publication channel open access: Partially open access channel
Abstract
Brief therapy for insomnia (BTI) is a short-term cognitive behavioral therapy for insomnia. At present, there is no study combining BTI with digital technology. However, in the context of the outbreak of coronavirus disease 2019 (COVID-19), patients with acute insomnia may need an online treatment which can quickly improve insomnia symptoms. Our team built a digital BTI (dBTI) platform based on the WeChat mini program. This research provides a framework design and a course design of dBTI, and evaluates the system via recruiting participants suffering from acute insomnia in pandemic. What's more, it explores patients’ adherence, the efficiency of the system and their relationship. As the result demonstrates, 68% of participants have completed more than half of the course with medium to high adherence. Gender, pre-sleep arousal scale (PSAS) somatic score and insomnia severity index (ISI) score have affected participants’ adherence, and higher adherence has led to better improvement in the severity of insomnia and somatic pre-sleep arousal. It is proved that the platform we built is effective, which not only offers an entry point for the study of how to set up a dBTI platform, but also provides theoretical basis for its clinical application.
Keywords: insomnia; treatment methods; brief therapy; e-healthcare; mobile apps; unusual conditions; COVID-19
Free keywords: Digital Medicine; dBTI; Platform Development; WeChat Mini Program; Adherence
Contributing organizations
Ministry reporting: Yes
Reporting Year: 2022
Preliminary JUFO rating: 1